Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.1160
+0.0010 (0.87%)
Sep 4, 2026, 4:13 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 4.93 million as of September 4, 2026. Its market cap has decreased by -43.98% in one year.
Market Cap
4.93M
Enterprise Value
6.70M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 4.93M, a decrease of -96.40%. That is a compound annual growth rate of -28.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.93M | -46.51% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 12.32M |
| Aptamer Group | 12.09M |
| Solvonis Therapeutics | 8.17M |
| Cizzle Biotechnology Holdings | 6.37M |
| CRISM Therapeutics | 6.10M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.20M |
| Nuformix | 4.31M |